Protein targets of angiotensin-converting enzyme inhibitors were associated with increased AD risk [39], and 11 other AD PWAS-significant genes (e.g., PVR, EPHX2, SNX32, CTSH) were consistent with a causal role in AD, acting via their cis-regulated brain protein abundance [19]. This evidence concerns the gene PVR and Alzheimer disease.